Anthony Swanda, Ph.D.
About Anthony Swanda, Ph.D.
Anthony Swanda, Ph.D., is the Senior Director of Process Development at Instil Bio, where he has worked since 2021. He holds a Ph.D. in Chemical Engineering from the University of California, Santa Barbara, and has extensive experience in cell therapy processes and control systems integration.
Work at Instil Bio
Anthony Swanda, Ph.D., serves as the Senior Director of Process Development at Instil Bio, a position he has held since 2021. Based in Thousand Oaks, California, he focuses on advancing bioprocess development, particularly in the realm of cell therapy. His role involves leading interdisciplinary teams to meet project milestones and deliverables. He also drives external partnerships with universities and vendors to foster innovation in the field.
Education and Expertise
Anthony Swanda earned his Doctor of Philosophy (Ph.D.) in Chemical Engineering from the University of California, Santa Barbara. He also holds a Master of Science (M.S.) and a Bachelor of Science (BSc) in Chemical Engineering from the same institution and the University of Washington, respectively. His expertise includes developing single-use consumables for cell therapy processes and integrating control systems using DCS, PLC, and HMI technologies. He employs data science techniques, such as design of experiments and multivariable data analysis, in his process development work.
Background
Before joining Instil Bio, Anthony Swanda had a lengthy tenure at Weyerhaeuser, where he held several positions from 1999 to 2017. He started as a Process Control Engineer, then advanced to Engineering Manager, and finally served as a Senior Engineering Specialist. Following his time at Weyerhaeuser, he worked as a Principal Process Engineer at Kite Pharma from 2018 to 2021, where he contributed to process engineering efforts in the biopharmaceutical sector.
Achievements
Throughout his career, Anthony Swanda has led cross-functional teams and managed complex projects in process development. He has successfully integrated advanced control systems and developed innovative solutions for cell therapy processes. His ability to leverage data science in process development has contributed to advancements in bioprocessing techniques, enhancing operational efficiencies and product quality.